118 related articles for article (PubMed ID: 38882361)
1. METTL14 inhibits the malignant processes of gastric cancer cells by promoting N6-methyladenosine (m6A) methylation of TAF10.
Zhao X; Lu J; Wu W; Li J
Heliyon; 2024 Jun; 10(11):e32014. PubMed ID: 38882361
[TBL] [Abstract][Full Text] [Related]
2. METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer.
Chen X; Xu M; Xu X; Zeng K; Liu X; Pan B; Li C; Sun L; Qin J; Xu T; He B; Pan Y; Sun H; Wang S
Mol Cancer; 2020 Jun; 19(1):106. PubMed ID: 32552762
[TBL] [Abstract][Full Text] [Related]
3. piRNA-14633 promotes cervical cancer cell malignancy in a METTL14-dependent m6A RNA methylation manner.
Xie Q; Li Z; Luo X; Wang D; Zhou Y; Zhao J; Gao S; Yang Y; Fu W; Kong L; Sun T
J Transl Med; 2022 Jan; 20(1):51. PubMed ID: 35093098
[TBL] [Abstract][Full Text] [Related]
4. The m6A methyltransferase METTL14 inhibits the proliferation, migration, and invasion of gastric cancer by regulating the PI3K/AKT/mTOR signaling pathway.
Liu X; Xiao M; Zhang L; Li L; Zhu G; Shen E; Lv M; Lu X; Sun Z
J Clin Lab Anal; 2021 Mar; 35(3):e23655. PubMed ID: 33314339
[TBL] [Abstract][Full Text] [Related]
5. METTL14 regulates M6A methylation-modified primary miR-19a to promote cardiovascular endothelial cell proliferation and invasion.
Zhang BY; Han L; Tang YF; Zhang GX; Fan XL; Zhang JJ; Xue Q; Xu ZY
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):7015-7023. PubMed ID: 32633395
[TBL] [Abstract][Full Text] [Related]
6. METTL14-mediated N
Liu Z; Sun T; Piao C; Zhang Z; Kong C
Cell Commun Signal; 2022 Mar; 20(1):36. PubMed ID: 35305660
[TBL] [Abstract][Full Text] [Related]
7. The m6A Methyltransferase METTL3-Mediated N6-Methyladenosine Modification of DEK mRNA to Promote Gastric Cancer Cell Growth and Metastasis.
Zhang HM; Qi FF; Wang J; Duan YY; Zhao LL; Wang YD; Zhang TC; Liao XH
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742899
[TBL] [Abstract][Full Text] [Related]
8. METTL14 promotes the migration and invasion of breast cancer cells by modulating N6‑methyladenosine and hsa‑miR‑146a‑5p expression.
Yi D; Wang R; Shi X; Xu L; Yilihamu Y; Sang J
Oncol Rep; 2020 May; 43(5):1375-1386. PubMed ID: 32323801
[TBL] [Abstract][Full Text] [Related]
9. METTL14-Mediated miR-30c-1-3p Maturation Represses the Progression of Lung Cancer via Regulation of MARCKSL1 Expression.
Li F; Zhao J; Wang L; Chi Y; Huang X; Liu W
Mol Biotechnol; 2022 Feb; 64(2):199-212. PubMed ID: 34586620
[TBL] [Abstract][Full Text] [Related]
10. LncRNA RASAL2-AS1 promotes METTL14-mediated m6A methylation in the proliferation and progression of head and neck squamous cell carcinoma.
Rong M; Zhang M; Dong F; Wu K; Cai B; Niu J; Yang L; Li Z; Lu HY
Cancer Cell Int; 2024 Mar; 24(1):113. PubMed ID: 38528591
[TBL] [Abstract][Full Text] [Related]
11. RNA m6A methyltransferase METTL14 promotes the procession of non-small cell lung cancer by targeted CSF1R.
Ren S; Xiao Y; Yang L; Hu Y
Thorac Cancer; 2023 Jan; 14(3):254-266. PubMed ID: 36448247
[TBL] [Abstract][Full Text] [Related]
12. N6-methyladenosine (m6A)-mediated up-regulation of long noncoding RNA LINC01320 promotes the proliferation, migration, and invasion of gastric cancer via miR495-5p/RAB19 axis.
Hu N; Ji H
Bioengineered; 2021 Dec; 12(1):4081-4091. PubMed ID: 34288797
[TBL] [Abstract][Full Text] [Related]
13. METTL14 promotes proliferation, migration, and invasion in endometriotic stromal cell growth by activating the ZEB1/MEK/ERK pathway.
Lv X; Li F
Gynecol Obstet Invest; 2024 Jun; ():. PubMed ID: 38934184
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of Methyltransferase-Like 14 Promotes Ovarian Cancer Cell Proliferation Through Stabilizing TROAP mRNA.
Li Y; Peng H; Jiang P; Zhang J; Zhao Y; Feng X; Pang C; Ren J; Zhang H; Bai W; Liu W
Front Oncol; 2022; 12():824258. PubMed ID: 35251990
[TBL] [Abstract][Full Text] [Related]
15. METTL14 Regulates PLAGL2/
Zhou Q; Lai X; Gao Y; Chen Q; Xu Y; Liu Y
J Oncol; 2023; 2023():4738586. PubMed ID: 36873735
[TBL] [Abstract][Full Text] [Related]
16. METTL14-mediated m
Fan HN; Chen ZY; Chen XY; Chen M; Yi YC; Zhu JS; Zhang J
Mol Cancer; 2022 Feb; 21(1):51. PubMed ID: 35164771
[TBL] [Abstract][Full Text] [Related]
17. METTL14 Inhibits Hepatocellular Carcinoma Metastasis Through Regulating EGFR/PI3K/AKT Signaling Pathway in an m6A-Dependent Manner.
Shi Y; Zhuang Y; Zhang J; Chen M; Wu S
Cancer Manag Res; 2020; 12():13173-13184. PubMed ID: 33380825
[TBL] [Abstract][Full Text] [Related]
18. The m6A Methyltransferase METTL14-Mediated N6-Methyladenosine Modification of PTEN mRNA Inhibits Tumor Growth and Metastasis in Stomach Adenocarcinoma.
Yao Q; He L; Gao X; Tang N; Lin L; Yu X; Wang D
Front Oncol; 2021; 11():699749. PubMed ID: 34476213
[TBL] [Abstract][Full Text] [Related]
19. METTL14 inhibits malignant progression of oral squamous cell carcinoma by targeting the autophagy-related gene RB1CC1 in an m6A-IGF2BP2-dependent manner.
Liang J; Cai H; Hou C; Song F; Jiang Y; Wang Z; Qiu D; Zhu Y; Wang F; Yu D; Hou J
Clin Sci (Lond); 2023 Sep; 137(17):1373-1389. PubMed ID: 37615536
[TBL] [Abstract][Full Text] [Related]
20. METTL3 regulates m6A in endometrioid epithelial ovarian cancer independently of METTl14 and WTAP.
Ma Z; Li Q; Liu P; Dong W; Zuo Y
Cell Biol Int; 2020 Dec; 44(12):2524-2531. PubMed ID: 32869897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
